GlassScriptPhysician profile
Jonathan C Mills
NPI 1457512121
$3,568.80
in general payments reported to CMS, 2019-2025
22 companies · $97.88 in 2025
The $97.88 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,563 · 2020: $953 · 2021: $92.55 · 2022: $276 · 2023: $421 · 2024: $166 · 2025: $97.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571 · Education: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.74 |
| Education | $113.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,226.70 | 2019-2020 | |
| Cochlear Americas | $755.59 | 2020-2024 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Stryker Corporation | $342.43 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $256.50 | 2019-2024 | Dupixent |
| Inspire Medical Systems, INC. | $210.00 | 2022-2023 | Inspire |
| Optinose US, INC. | $166.96 | 2019-2024 | |
| Medtronic, INC. | $143.63 | 2023-2025 | Propel |
| Arbor Pharmaceuticals, INC. | $71.86 | 2019-2020 | |
| Aerin Medical INC. | $69.38 | 2022-2024 | |
| Intersect Ent, INC. | $49.32 | 2019-2022 | |
| Smith+Nephew, INC. | $45.24 | 2020-2025 | Halo |
| Hologic Sales and Service, LLC | $41.60 | 2023-2024 | Coolseal Generator |
| Glaxosmithkline, LLC. | $31.75 | 2024 | Nucala |
| Genzyme Corporation | $29.99 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $21.06 | 2025 | Tezspire |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20.94 | 2019 | |
| Bard Access Systems, INC. | $15.76 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.54 | 2022 | |
| Acclarent, INC | $14.08 | 2019 | |
| Cook Medical LLC | $13.65 | 2019 | |
| Xoran Technologies LLC | $13.65 | 2020 | |
| Merck Sharp & Dohme LLC | $13.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.